Bing

SEARCH HISTORY

Shares of Synergy Pharmaceuticals Inc. were trading up +1.74 or +21.19 percent to $9.95 per share in Thursday's premarket after the company announced positive results in the second Phase 3 trial of its gastrointestinal drug plecanatide in patients ...
Investor Guide · 7/30/2015
Synergy Pharmaceuticals
One Horizon Grp Inc (OHGI) posted a gap up of 0.15 points or 7.25 pct above its last close of $2.07. The company < traded at $2.16 + 0.09 (4.35 pct). BioPharmX Corp (BPMX) posted a gap up of 0.06 points or 2.91 pct …
Fx Pips · 7/31/2015
points
Synergy Pharmaceuticals (NASDAQ:SGYP)‘s stock had its “buy” rating reiterated by Canaccord Genuity in a note issued to investors on Friday, Market Beat.com reports. They presently have a $19.00 target price on the biopharmaceutical …
Ticker Report · 7/31/2015
More from Bing News
These bearish bets now account for more than one-quarter of the stock's available float, or 3.5 times SGYP's average daily trading volume. UNIS last night unveiled a patch to instantly release insulin to patients with type …
Schaeffer's Investment Research · 7/30/2015
Synergy Pharmaceuticals Inc
Conditions do change though, so while these stocks currently offer what day traders are looking for, weeks or months from now they may not. Synergy Pharmaceuticals, Inc (SGYP) highlights a problem with relying only on averages. Two days in June ...
Investopedia · 7/29/2015
day traders
Investors in Synergy Pharmaceuticals Inc (SGYP) saw new options become available this week, for the September 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SGYP
The Street · 7/21/2015
What: Shares of Synergy Pharmaceuticals (NASDAQ:SGYP) climbed by nearly 19% today on tremendous volume after the company reported that its lead experimental drug, plecanatide, met its primary endpoint in a second late-stage study as a treatment …
The Motley Fool · 7/30/2015
Synergy Pharmaceuticals
I have a few odds and ends in play but nothing substantive. Synergy Pharmaceuticals (SGYP), my Stock of the Week, is acting better and I am continuing to look for ways to deploy capital. I have nibbled on Cigna (CI) on the takeover speculation, but putting ...
realmoney.thestreet.com · 7/23/2015
Inc. SGYP shares surged 185.6% year to date boosted by its new gastrointestinal drug. Merger and acquisition activities, as companies look forward to buy drug pipelines rather than developing their own, have also boosted biotech stocks. In 2015 ...
NASDAQ · 7/21/2015
Nasdaq Stocks
NEW YORK, July 24, 2015 /PRNewswire via COMTEX/ -- NEW YORK, July 24, 2015 /PRNewswire/ -- Equity Research Institute has initiated coverage on the following equities: Synergy Pharmaceuticals Inc. SGYP ... Inc.'s stock finished Thursday's session …
Market Watch · 7/24/2015